Inherited Thromophilia and Thrombotic Risks in Inflammatory Bowel Disease During Activity and Remission
NCT06691451 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 93
Last updated 2024-11-15
Summary
Inherited thombopllia and thrombotic risks in inflammatory bowel Disease during activity and remission
Conditions
- Inflammatory Bowel Diseases
Sponsors & Collaborators
-
Assiut University
collaborator OTHER -
Asmaa mohammed abdelaal abdelaal
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-11-30
- Primary Completion
- 2026-12-31
- Completion
- 2027-03-31
More Related Trials
-
Clinical Characteristics and Risk Factors of Children Suffering From Inflammatory Bowel Diseases At Assiut University Children Hospital
NCT05002166 ·Status: RECRUITING
-
Biological Therapy in Patients With Inflammatory Bowel Disease
NCT05599867 ·Status: UNKNOWN
-
Airway Involvement In Inflammatory Bowel Disease
NCT06090045 ·Status: NOT_YET_RECRUITING
-
Role of Altered Intestinal Permeability and Lipopolysaccharide in Thrombotic Risk and Vascular Injury in IBD Patients
NCT06772350 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Long-term Outcome of TNF Alpha Therapy in IBD
NCT04575701 ·Status: COMPLETED
-
Combination Therapy With Two Biologicals
NCT05135221 ·Status: COMPLETED
-
Preemptive HLA Genotyping for the Safe Use of Infliximab-combination Therapy in Inflammatory Bowel Disease
NCT04109300 ·Status: UNKNOWN ·Phase: NA
-
Prevalence of Lymphoma in IBD
NCT00577538 ·Status: COMPLETED
-
Infliximab and Adalimumab in Inflammatory Bowel Disease Patients.
NCT05291039 ·Status: COMPLETED ·Phase: NA
-
Von Willebrand Antigen and Activity as Novel Biomarkers of Hemostasis in Inflammatory Bowel Disease
NCT03715673 ·Status: UNKNOWN
-
Medico-economic Evaluation of the Therapeutic Drug Monitoring of Anti-TNF-α Agents in Inflammatory Bowel Diseases
NCT02508012 ·Status: COMPLETED ·Phase: NA
-
Microbiome and Genetic Analysis of Familial IBD
NCT03515070 ·Status: COMPLETED
-
Genetic, Serological Fecal and Clinical Markers in Siblings of Children With Inflammatory Bowel Disease
NCT02181153 ·Status: COMPLETED ·Phase: NA
-
Role of C-Reactive Protein /Albumin Ratio in Evaluation of Disease Activity in Patients With Inflammatory Bowel Disease
NCT05738915 ·Status: UNKNOWN
-
Study of Ischemic Colitis Compared to Other Diagnoses in Patients With Lower Gastrointestinal Bleeding
NCT01078324 ·Status: COMPLETED
-
Evaluation of the Clinical and Immunological Impact of Two Therapeutic Strategies in Chronic Inflammatory Diseases
NCT03370601 ·Status: TERMINATED ·Phase: NA
-
Investigation of the Correlation Between Polyamine Levels and Their Key Enzymatic Activities in Association With Inflammatory Bowel Disease Progression
NCT06995170 ·Status: RECRUITING
-
Long-term Functional Outcome of Children With Inflammatory Bowel Disease
NCT02152241 ·Status: COMPLETED
-
Therapeutic Drug Monitoring for Biological Therapy in Pediatric Inflammatory Bowel Disease
NCT06954311 ·Status: RECRUITING
-
Predictors of Mucosal Healing in Inflammatory Bowel Disease (IBD) Patients Treated With Anti-TNF
NCT01605175 ·Status: COMPLETED
-
Lymphoid Tyrosine Phosphatase Gene Polymorphisms in Inflammatory Bowel Disease
NCT04284878 ·Status: UNKNOWN
-
A Prospective Study on the Incidence and Risk Factors Related to Infection in Patients With Inflammatory Bowel Disease
NCT02904590 ·Status: COMPLETED
-
TDM-based Infliximab Treatment for Active Perianal Fistulizing Crohn's Disease
NCT06051253 ·Status: RECRUITING ·Phase: PHASE4
-
Immune Function in Offsprings of Females With Inflammatory Bowel Disease
NCT02079441 ·Status: COMPLETED
-
The Comparison Between the Biomarkers in Inflammatory Bowel Disease Patients and General Control Group
NCT03778918 ·Status: UNKNOWN